跳至主要内容
临床试验/CTRI/2024/04/066458
CTRI/2024/04/066458尚未招募4 期

A comparative study to assess the efficacy and safety of Vortioxetine versus sertraline in patients suffering from Anxiety Disorder - NI

Mitsha Nagpal0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Both male and female patients aged between 18 and 60 years.
  • 2. Those giving written consent/guardians giving written consent (in cases where the patients were too ill to understand the process of informed consent and give an informed choice.)
  • 3. People diagnosed with anxiety disorder as per ICD-10 diagnostic criteria.
  • 4. HAM-A score =18

排除标准

  • 1. Systemic or Neurological Disorder affecting Cognition, Behavior or Mental Status.
  • 2. Substance dependence except for Nicotine and Caffeine within the past month of entering the study.
  • 3. Long-standing medical or surgical illnesses.
  • 4. Patients with mental retardation or organic brain disorders.
  • 5. Patients suffering from neurological, metabolic and vascular conditions affecting sexual function.

研究者

发起方
Mitsha Nagpal

相似试验